Clinical trial
Placebo Controlled Phase II Clinical Trial: Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
NCT04292535 is registered in ClinicalTrials.gov with Michigan State University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Placebo Controlled Phase II Clinical Trial: Safety and Efficacy of Combining Intranasal Insulin & Acute Exercise
- Lead sponsor
- Michigan State University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 15, 2018
- Completion date
- February 20, 2020
- Enrollment
- 116 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
exercise, insulin